Annals of Neurology, July 2006, Vol. 60, No 1, 22-31.
Merit. E. Cudkowicz, MD, MSc, Jeremy. M. Shefner, MD, PhD, David. A. Schoenfeld, PhD, Hui. Zhang, Katrin. I. Andreasson, MD, Jeffrey D. Rothstein, MD PhD, Daniel. B. Drachman, MD and the Northeast ALS Consortium.
Revised Statistical MUNE in the Celecoxib/ALS Trial Muscle and Nerve, 2007, in press. J. M. Shefner, M. E. Cudkowicz, H. Zhang, D. Schoenfeld, D. Jillapalli, and the Northeast ALS Consortium. Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS
Neurology, 2005: 65(11):1834-6 K. L. Ferrante, BA, J. Shefner, MD, PhD, H. Zhang, MS, R. Betensky, PhD, M. O'Brien, MPH, PT, H. Yu, MS, M. Fantasia, MPH, J. Taft, MPAS, PA, M. F. Beal, MD, B. Traynor, MD, K. Newhall, BS, P. Donofrio, MD, J. Caress, MD, C. Ashburn, RN, MSN, B. Freiberg, PT, C. O'Neill, BS, C. Paladenech, RRT, T. Walker, RN, BSN, A. Pestronk, MD, B. Abrams, RN, J. Florence, MHS, DPT, R. Renna, RN, J. Schierbecker, MHS, PT, B. Malkus, MHS, PT and M. Cudkowicz, MD, MSc Arimoclomol at Dosages up to 300 mg/day is Well Tolerated and Safe in Amyotrophic Lateral Sclerosis Muscle & Nerve, in press 2008 Merit E. Cudkowicz, MD, MSc, Jeremy M. Shefner, MD, PhD, Elizabeth Simpson, et al. Medications and laboratory parameters as prognostic factors in amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis, 2008 (Accepted for publication) Qureshi M, Shui A, DiBernardo A, Brown Jr R, Schoenfeld D, Cudkowicz M. Phase 2 Study of Sodium Phenylbutyrate in ALS
Amyotrophic Lateral Sclerosis, Under Review, 2008.
Cudkowicz ME, Andres PL, MacDonald SA, Bedlack R, Choudry R, Brown RH, et al: Abstract (with poster) presented at ANA meeting, Chicago, IL, October 2006: NEALS Arimoclomol Sites: A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS Annals of Neurology, 2006; 60(S10); S13 M. Cudkowicz, J. Shefner, R. Brown, E. Simpson, H. Yu, H. Zhang, A. Opoliner, D. Grasso, D. Schoenfeld, S. Wieland, J. Barber Abstracts presented at 17th International Symposium on ALS/MND, Japan, December 2006: Challenges of Data Management in Web-based Multi-site Clinical Trials in Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis, 2006. 7:S1, Pages 1-180; 57-58. A.V. Sherman, M.E. Cudkowicz, H. Yu, S. Balakrishna, A.F. Opoliner Levetiracetam Treatment for Spasticity in Motor Neuron Diseases Amyotrophic Lateral Sclerosis, 2006. 7:S1, Pages 1-180; 111-112. R. Bedlack, M. Bellanich, M. Bromberg, M. Cudkowicz A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS (Poster was presented) Amyotrophic Lateral Sclerosis, 2006. 7:S1, Pages 1-180; 113. M. Cudkowicz, J. Shefner, E. Simpson, D. Grasso, A. Sherman, H. Yu, A Opoliner, S. Balakrishna, D. Schoenfeld, H. Zhang, D. Finkelstein, J. Taft, M. Watson, A. DiBernardo, D. Pulley, A. Verma, D. Koggan, J. Steele, R. Bedlack, K. Grace, T. Heiman-Patterson, C. Barr, R. Barohn, M. Walsh, L. Herbelin, Z. Simmons, H. Stephens, E. Ensrud, M. Zimmerman, W. David, S. Conn, T. Mozaffar, V. Martin, J. Hung, D. Milan, S. Wieland, J. Barber, R. Brown Unified Electronic Data Capture and Data Management System for Clinical Trials and Biomarker Studies in ALS Amyotrophic Lateral Sclerosis, 2006. 7:S1, Pages 1-180; 115-116. A.V. Sherman Safety and Dose Escalating Study of Oral Sodium Phenylbutyrate in Subjects with ALS Cudkowicz ME, Andres PL, Schoenfeld D, Zhang H, Sherman A, Yu H, Opoliner A, Choudry R, Kruczek K, MacDonald S, Matson W, Smith K, Hetherington W, Loya P, Bedlack R, Golightly Y, Maragakis N, Clawson L, Mosier D, Ali N, Kasarskis E, Taylor D, Zivkovic S, Brice V, Sams L, Story M, Ferrante K, Shefner J, Taft J, Brown R Ferrante, RJ Application of a Finite State Machine Model for Management of Multi-Site Clinical Trials in ALS Sherman A., Opoliner A., Yu H., Chan M., Cudkowicz M., 18th International Symposium on ALS/MND, Toronto, Canada, December 2007 Comparison of Controlled Medical Vocabularies for Adverse Event Recoding in a Multi-Center Clinical Trial in ALS Qureshi M., Sherman A., Yu H., Debernardo A., Choudry R., Cudkowicz M. 18th International Symposium on ALS/MND, Toronto, Canada, December 2007 Design and Implementation of a Multi-Phase, Adaptive-Design Clinical Trial for Subjects with ALS Swartz A., Shefner J., Yu H., Thornell B., Sherman A., Cudkowicz M. 18th International Symposium on ALS/MND, Toronto, Canada, December 2007 Advantages of Automated Serious Adverse Events Management (SAEM) in Multi-site Clinical Trials in ALS Sherman A.V., Opoliner A.F., Hong Yu, Chan M., Andres P.L., Cudkowicz M.E. 132d Annual Meeting of the American Neurological Association, Washington, D.C., October 2007 Introduction of Clinical Trials Management Systems in Web-based Multi-site Clinical Trials in Neurology Research Sherman A.V., Cudkowicz M.E., Hong Yu, April Opoliner. 59th American Academy of Neurology, Boston, April 2007 Challenges of Data Management in Web-based Multi-site Clinical Trials in ASL Sherman A.V. 17th International Symposium on ALS/MND, Yokohama, Japan, December 2006 Unified Electronic Data Capture and data management System for Clinical Trials and Biomarker Studies in ALS Sherman A.V., Cudkowicz M.E. 17th International Symposium on ALS/MND, Yokohama, Japan, December 2006 Data Exchange Specifications for Semantically Heterogeneous Data Sources in ALS Research Sherman A.V., Cudkowicz M.E.. 131st Annual Meeting of the American Neurological Association, Chicago, October 2006 Identification of Metabolic and Protein Biomarkers in the Cerebrospinal Fluid for Amyotrophic Lateral Sclerosis Dibernardo, K.R. Kruczek, E.A. Welsh, K. Newhall, G. Royce-Nagel, K. Ferrante, A. Sherman, R. Bowser, R.H. Brown, M.E. Cudkowicz Massachusetts General Hospital Clinical Research Day, May 2006 Introduction of Electronic Data Capture and Data Management Technology to Investigator-initiated Clinical Trials and Biomarker Studies in an Academic Environment Sherman A.V., Cudkowicz M.E. 16th International Symposium on ALS/MND, Dublin, Ireland, December 2005 Data Exchange Specifications for Biomarker Studies and Clinical Trials in ALS Sherman A.V., Cudkowicz M.E., Brown R.H., Miller R.. 16th International Symposium on ALS/MND, Dublin, Ireland, December 2005 |